Condition: Hereditary Spastic Paraplegia · Sponsor: IRCCS Eugenio Medea
Hereditary Spastic Paraplegia (HSP) is a diverse group of genetic neurological conditions causing progressive weakness and spasticity in the lower limbs, severely reducing balance and gait capabilities. There is currently a lack of structured neurorehabilitation programs aimed at improving gait in adults with HSP. This protocol seeks to assess the feasibility and effectiveness of a structured training approach focusing on flexibility, muscle strength, motor control, balance, and aerobic capacity. To this end, twenty adults diagnosed with HSP will engage in 10 to 16 sessions, each lasting 60 to 120 minutes, guided by a therapist once or twice a week, depending on individual preferences. At the end of the program, participants will receive a transfer package, including written instructions (a manual) and video tutorials, to encourage ongoing exercise at home. Assessments will occur before the intervention (T0), immediately after (T1), and three months later (T2). The primary outcomes will measure the feasibility of the program, including recruitment, retention, adherence, the absence of adverse events, and patient satisfaction. Secondary outcomes will focus on improvements in gait capabilities such as gait endurance and gait speed.
This description comes directly from the study's public registry record.
Leonardo Boccuni, PhD · 003904384141 · leonardo.boccuni@lanostrafamiglia.it
Marco Bortolini, BSc · 003904389062 · marco.bortolini@lanostrafamiglia.it
Always discuss trial participation with your own doctor first.
| Scientific Institute, IRCCS E. Medea, Department of Bosisio Parini, Lecco, Italy. | Bosisio Parini, Lombardy, Italy | Recruiting |
| Scientific Institute, IRCCS E. Medea, Department of Pieve di Soligo, Treviso, Italy | Pieve di Soligo, Veneto, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06742697